QOL Predicts Survival, Raises Issues in Lung Cancer Trial – Medscape

by lowes1 on October 2, 2013

QOL Predicts Survival, Raises Issues in Lung Cancer Trial
Medscape
ATLANTA — A new analysis of quality-of-life (QOL) data from a major lung cancer clinical trial, which showed that high-dose is not better than standard-dose radiation in stage III patients, has raised questions about the results. Baseline QOL scores

View full post on lung cancer – Google News

Leave a Comment

Previous post:

Next post: